company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3351274.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3351274.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,34945.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,20718.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,210101.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,179346.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2906164.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2906164.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2560.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,2560.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,2560.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4003999.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-17362.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,32362.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4018999.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4018999.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q3,2012-07-01,2012-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,1115395.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,-8438763.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2369237.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-10808000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,-3608.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q4,2012-10-01,2012-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1608.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q4,2012-10-01,2012-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,15751000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q4,2012-10-01,2012-12-31,,netchangeincash,othernetchangesincash,Other Net Changes in Cash,+,debit,usd,-1593990.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2012.0,Q4,2012-10-01,2012-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,3347010.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-4239000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-4239000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,32000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,478000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,474000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,628000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-2627000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-2627000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,1000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q1,2013-01-01,2013-03-31,2014-05-12 16:11:43+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-2626000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6921000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6921000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,17000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-1000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2749000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,977000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-3179000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-3179000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-18000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,55000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,37000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,37000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1067000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,16827000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,123000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,15883000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,15883000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q2,2013-04-01,2013-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,12741000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5239000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5239000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,11000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,13000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,385000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,53000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-4777000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-4777000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-13521000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,135000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-13386000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-13386000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,1067000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,-3000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,72368000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,73432000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,73432000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q3,2013-07-01,2013-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,55269000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9689133.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9689133.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,10551.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-424709.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,1003096.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1569834.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7530361.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7530361.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-13373.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-11155822.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,10265.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,3504791.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-7654139.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-7654139.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofpreferredequity,Issuance of Preferred Equity,+,debit,usd,235.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-174169.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,274.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-173660.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-173660.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2013.0,Q4,2013-10-01,2013-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15358160.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7874000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7874000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,12000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,53000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,758000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2053000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9104000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9104000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-273000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-3000000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuinginvestingactivities,divestitures,Divestitures,+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4426000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuinginvestingactivities,otherinvestingactivitiesnet,"Other Investing Activities, net",+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1153000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1153000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingfinancingactivities,repurchaseofpreferredequity,Repurchase of Preferred Equity,+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,52000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,52000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,52000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q1,2014-01-01,2014-03-31,2014-05-12 16:11:43+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7899000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9238000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9238000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,41000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,53000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,948000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2118000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-6078000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-6078000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-365000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-1800000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,12000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2500000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,347000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,347000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,4947000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,90000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5037000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5037000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-694000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9806000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9806000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,51000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,62000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,950000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,104000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8631000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8631000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-215000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,1000000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,785000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,785000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-31000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,165000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,134000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,134000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-7712000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8208000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8208000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-20000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-43288000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,4425000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-38883000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-38883000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,91731000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,166000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,91897000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,91897000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,44806000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11466000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11466000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,59000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,35000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2072000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,29000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9263000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9263000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-7000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-70354000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12813000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-57548000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-57548000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,190150000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,264000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,190414000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,190414000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q1,2015-01-01,2015-03-31,2016-05-04 08:33:11+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,123603000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12395000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12395000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,56000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,159000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,2898000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,661000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8614000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8614000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-97780000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,6000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,27182000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-70606000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-70606000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-168000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,534000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,366000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,366000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-78854000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12801000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12801000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,54000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,226000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3368000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2684000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-11830000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-11830000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-76000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-74061000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,3000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,36875000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-37259000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-37259000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,126000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,126000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-48963000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13122000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13122000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,67000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,288000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4435000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-95000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-8449000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-8449000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-228000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-38364000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,15000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43922000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5345000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5345000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-384000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-384000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3488000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14585000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14585000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,64000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,267000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4556000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-105000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-9803000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-9803000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-70252000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,40290000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-29962000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-29962000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-391000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,27000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-364000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-364000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q1,2016-01-01,2016-03-31,2017-05-04 16:33:15+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-40129000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14035000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14035000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,63000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,250000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4121000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2294000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-7307000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-7307000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-42370000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,61633000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19258000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19258000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-398000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,8000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-390000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-390000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q2,2016-04-01,2016-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11561000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17402000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17402000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,63000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,284000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3709000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-958000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-14304000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-14304000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50904000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,63974000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,13070000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,13070000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-404000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,10000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-394000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-394000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-1628000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-28956000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-28956000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,62000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,213000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,3571000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,8794000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-16316000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-16316000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-89000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-33704000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,41545000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,7752000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,7752000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-411000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-411000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-411000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-8975000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-40541000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-40541000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,69000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,148000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4150000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1858000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34316000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34316000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-14000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-28191000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,44373000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16168000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16168000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-417000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,267000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-150000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-150000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q1,2017-01-01,2017-03-31,2018-05-02 16:31:03+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-18298000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43337000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43337000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,65000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,103000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4980000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11961000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-26228000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-26228000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-5000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8578000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,35686000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,27103000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,27103000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-424000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,55000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-369000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-369000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,506000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45219000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45219000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,62000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,63000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4941000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,4269000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-35884000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-35884000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-176204000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,48681000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-127523000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-127523000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-431000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,164079000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,410000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,164058000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,164058000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,651000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37891000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37891000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,62000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,20000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,4534000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1599000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34874000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34874000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-6604000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,55003000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,48399000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,48399000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-437000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,-79000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,435000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-81000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-81000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,13444000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46130000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46130000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,61000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5921000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3073000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-43221000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-43221000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-14620000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,44903000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,30283000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,30283000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-445000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,9738000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,9293000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,9293000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q1,2018-01-01,2018-03-31,2019-05-08 16:32:47+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3645000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45730000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45730000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,63000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-57000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5723000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,803000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-39198000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-39198000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-5920000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,37490000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,31570000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,31570000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-451000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1636000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1185000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1185000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-6443000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49911000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49911000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,67000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-77000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,5495000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,6899000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-37527000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-37527000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-46000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-4941000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,45015000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,40028000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,40028000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-153000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,27000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-126000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-126000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,2375000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-60039000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-60039000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,74000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-83000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6829000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,24527000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-28692000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-28692000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-105000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,38673000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,38568000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,38568000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,342000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,342000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,342000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,10218000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,87379000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,87379000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,71000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-75000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6636000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-2320000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,91691000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,91691000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-189000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,45885000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,45696000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,45696000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,0.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1669000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1669000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1669000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q1,2019-01-01,2019-03-31,2020-05-06 17:26:23+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,139056000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-54221000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-54221000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,55000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-46000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6563000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-6360000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-54009000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-54009000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-234000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,26950000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,26716000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,26716000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,124649000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1887000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,126536000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,126536000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,99243000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-68377000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-68377000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,92000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-19000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10323000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-48000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-58029000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-58029000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-358000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26630000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,21675000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-5313000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-5313000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,-225000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,1201000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,976000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,976000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-62366000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-61946000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-61946000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,101000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-60000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10482000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1429000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-49994000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-49994000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-172000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-7696000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-2868000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-2868000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,7014000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,7014000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,7014000.0
Esperion Therapeutics Inc,ESPR,549300OFU56UKEWVUS92,0001434868,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-45848000.0
